[go: up one dir, main page]

TR200001232T2 - Uzatılmış tahliye formülasyonu. - Google Patents

Uzatılmış tahliye formülasyonu.

Info

Publication number
TR200001232T2
TR200001232T2 TR2000/01232T TR200001232T TR200001232T2 TR 200001232 T2 TR200001232 T2 TR 200001232T2 TR 2000/01232 T TR2000/01232 T TR 2000/01232T TR 200001232 T TR200001232 T TR 200001232T TR 200001232 T2 TR200001232 T2 TR 200001232T2
Authority
TR
Turkey
Prior art keywords
extended release
release formulation
venlafaxine hydrochloride
antidepressant
vomiting
Prior art date
Application number
TR2000/01232T
Other languages
English (en)
Inventor
Marie Sherman Deborah
Clifton Clark John
Ulrick Lamer John
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25508423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200001232(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of TR200001232T2 publication Critical patent/TR200001232T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu bulus, uzatilmis tahliye dozaj formülasyonu ve onun venlafaksin hidroklorid ve antidepresan birin dozaj biçimi ile ilgilidir ve günde iki ya da daha fazla uygulanmasi gereken geleneksel tablet formülasyonlarindan daha iyi kan plasma seviyeleri saglar ve ayrica geleneksel tabletlerden daha az mide bulantisi ve kusmaya neden olur. Birinci yönünde bu bulus, venlafaksin hidroklorid ve mikrokristal selülozdan olusan yani hidroksipropilselüloz eklenmeden gelistirilmis bir uzatilmis tahliye sferoidleri çekirdegi saglar.
TR2000/01232T 1997-11-05 1998-11-03 Uzatılmış tahliye formülasyonu. TR200001232T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96432897A 1997-11-05 1997-11-05

Publications (1)

Publication Number Publication Date
TR200001232T2 true TR200001232T2 (tr) 2000-12-21

Family

ID=25508423

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01232T TR200001232T2 (tr) 1997-11-05 1998-11-03 Uzatılmış tahliye formülasyonu.

Country Status (38)

Country Link
EP (1) EP1028718B1 (tr)
JP (1) JP2001521892A (tr)
KR (1) KR20010031797A (tr)
CN (1) CN1278165A (tr)
AR (1) AR014012A1 (tr)
AT (1) ATE237320T1 (tr)
AU (1) AU747978B2 (tr)
BG (1) BG104397A (tr)
BR (1) BR9813179A (tr)
CA (1) CA2305242A1 (tr)
CL (1) CL2004001705A1 (tr)
CO (1) CO5011060A1 (tr)
CZ (1) CZ20001659A3 (tr)
DE (1) DE69813602T2 (tr)
DK (1) DK1028718T3 (tr)
EA (1) EA200000487A1 (tr)
EE (1) EE04577B1 (tr)
ES (1) ES2196620T3 (tr)
GE (1) GEP20043198B (tr)
HR (1) HRP20000213B1 (tr)
HU (1) HU225238B1 (tr)
ID (1) ID26317A (tr)
IL (1) IL135457A0 (tr)
MA (1) MA24691A1 (tr)
NO (1) NO20002126L (tr)
NZ (1) NZ504460A (tr)
PA (1) PA8462501A1 (tr)
PE (1) PE128699A1 (tr)
PL (1) PL341141A1 (tr)
PT (1) PT1028718E (tr)
SK (1) SK6472000A3 (tr)
SV (1) SV1998000131A (tr)
TR (1) TR200001232T2 (tr)
TW (1) TW555568B (tr)
UA (1) UA77145C2 (tr)
UY (2) UY25234A1 (tr)
WO (1) WO1999022724A2 (tr)
ZA (1) ZA9810081B (tr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20013607A3 (cs) * 1999-04-06 2002-06-12 Sepracor Inc. Farmaceutický prostředek
SK286865B6 (sk) * 1999-05-20 2009-06-05 Elan Pharma International Limited Multičasticový farmaceutický prostriedok s riadeným uvoľňovaním selektívneho inhibítora spätného príjmu serotonínu a jeho použitie
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
AU2002348266A1 (en) * 2001-12-05 2003-06-23 Wyeth Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
AU2002247945A1 (en) * 2001-12-13 2003-06-23 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
EP1474123A1 (en) * 2002-01-03 2004-11-10 LEK Pharmaceuticals D.D. Controlled release pharmaceutical formulation containing venlafaxine
WO2003082261A1 (en) * 2002-03-28 2003-10-09 Synthon B.V. Extended release venlafaxine formulations
WO2003082805A1 (en) 2002-03-28 2003-10-09 Synthon B.V. Low water-soluble venlafaxine salts
AU2003221535A1 (en) 2002-03-28 2003-10-13 Synthon B.V. Venlafaxine besylate
AR039165A1 (es) * 2002-03-28 2005-02-09 Synthon Bv Venlafaxina base
FR2845289B1 (fr) 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
CA2415154C (en) * 2002-12-24 2009-06-16 Biovail Laboratories Inc. Modified release formulations of selective serotonin re-uptake inhibitors
DE10350194B4 (de) * 2003-10-28 2005-11-10 Bioplanta Arzneimittel Gmbh Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen
TW200503670A (en) * 2003-03-28 2005-02-01 Sandoz Ag Venlafaxine compositions
SI1502587T1 (sl) * 2003-07-30 2007-02-28 Pharmathen Sa Formulacija z zadrzevanim sproscanjem za Venlafaxin hidroklorid
HUP0303382A2 (hu) * 2003-10-10 2005-08-29 EGIS Gyógyszergyár Rt. Venlafaxin-hidroklorid-tartalmú pelletek
WO2005074895A1 (en) * 2004-02-04 2005-08-18 Alembic Limited Extended release coated microtablets of venlafaxine hydrochloride
US7776358B2 (en) 2004-07-22 2010-08-17 Synthon Ip Inc. Extended release venlafaxine besylate tablets
CA2648278C (en) * 2006-04-03 2019-05-28 Isa Odidi Drug delivery composition
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
CN102772390B (zh) * 2012-08-16 2014-01-08 乐普药业股份有限公司 一种盐酸文拉法辛缓释胶囊及其制备方法
FR3080278B1 (fr) * 2018-04-11 2021-04-30 Ghs Patents Ltd Procede de fabrication d'un spheroide de cannabidiol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
HK1029056A1 (en) 2001-03-23
EE04577B1 (et) 2006-02-15
CA2305242A1 (en) 1999-05-14
CN1278165A (zh) 2000-12-27
EP1028718A2 (en) 2000-08-23
HRP20000213A2 (en) 2000-12-31
DE69813602D1 (de) 2003-05-22
KR20010031797A (ko) 2001-04-16
HRP20000213B1 (en) 2004-04-30
SK6472000A3 (en) 2000-11-07
SV1998000131A (es) 1999-11-18
PT1028718E (pt) 2003-07-31
DE69813602T2 (de) 2003-11-06
EP1028718B1 (en) 2003-04-16
GEP20043198B (en) 2004-03-25
BG104397A (en) 2001-02-28
PA8462501A1 (es) 2000-05-24
HU225238B1 (en) 2006-08-28
CZ20001659A3 (cs) 2001-10-17
WO1999022724A3 (en) 1999-07-22
PL341141A1 (en) 2001-03-26
HUP0004287A3 (en) 2002-05-28
NZ504460A (en) 2003-01-31
UY25692A1 (es) 2000-03-31
HUP0004287A2 (hu) 2002-04-29
NO20002126L (no) 2000-05-04
ATE237320T1 (de) 2003-05-15
ID26317A (id) 2000-12-14
UY25234A1 (es) 2000-12-29
CL2004001705A1 (es) 2005-06-03
JP2001521892A (ja) 2001-11-13
ES2196620T3 (es) 2003-12-16
BR9813179A (pt) 2000-08-22
ZA9810081B (en) 2000-05-04
PE128699A1 (es) 2000-01-06
UA77145C2 (en) 2006-11-15
EA200000487A1 (ru) 2000-10-30
NO20002126D0 (no) 2000-04-26
AU1300399A (en) 1999-05-24
IL135457A0 (en) 2001-05-20
WO1999022724A2 (en) 1999-05-14
EE200000212A (et) 2001-04-16
AR014012A1 (es) 2001-01-31
MA24691A1 (fr) 1999-07-01
TW555568B (en) 2003-10-01
AU747978B2 (en) 2002-05-30
CO5011060A1 (es) 2001-02-28
DK1028718T3 (da) 2003-07-28

Similar Documents

Publication Publication Date Title
TR200001232T2 (tr) Uzatılmış tahliye formülasyonu.
Pierpoint Salicylic acid and its derivatives in plants: medicines, metabolites and messenger molecules
KR950031052A (ko) 알푸조신 히드로클로라이드의 서방성 투약형태
TR200001761T2 (tr) Çoklu terapilerde aktif esasların tatbiki için bir çift kapsül.
KR970064599A (ko) 서방성 제형
FI906245A0 (fi) L-carnitinhaltiga preparat.
YU53101A (sh) Tableta sa produženim oslobađanjem gliklazida posle oralne primene
ATE223207T1 (de) Tablette mit instant- und verzögerte freisetzung von einen oder mehrere wirkstoffe
ES2181417T3 (es) Formulacion de capsulas o tabletas de efavirenz de disolucion rapida usando super-desintegrantes.
TR200001942T2 (tr) Opioid agonist/antagonist kombinasyonlar
EA200300081A1 (ru) Гидрогель-управляемая лекарственная форма
DE59802670D1 (de) Osmotisches arzneimittelfreisetzungssystem
TR199700917T1 (tr) Oral farmasötik dozaj formlari.
CO5611100A2 (es) Preparacion farmaceutica que contiene oxicodona y naloxona
SE9301057D0 (sv) Controlled release prepration
TNSN98125A1 (fr) Sels de sertraline, et formes posologiques de sertraline a liberation prolongee, et procedes pour leur preparation
PT841904E (pt) Composicoes farmaceuticas orais com libertacao diferida de inibidores reversiveis da bomba de protoes
TR200002214T2 (tr) Omeprazolün midede bozunmayan mikro-zerreleri, üretim işlemleri ve farmasötik preparasyonlar.
TR199800644T2 (tr) Bir apoptoz inhibitörü olarak y-RAR antagonist ligandi ya da alfa-RAR antagonist ligandi.
ATE304844T1 (de) Entzündungshemmende pharmazeutische formulierungen
MXPA03004209A (es) Composicion farmaceutica o cosmetica y uso de un inhbidor de proteina cinasa c con un inhibidor de metaloproteasas de la matriz para inhibir la migracion de celulas de langerhans.
ATE361743T1 (de) Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
BRPI0012553B8 (pt) pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso
TR200200978T2 (tr) Yeni mirtazapin formülasyonu